SCHEMBL7140133

SCHEMBL7140133

CC(C)(C)OC(=O)Nc1cc(OCC2COC(C)(C)O2)c(C#Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.33
ADRA2A P08913 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33
P2RY6 Q15077 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPK1 P28482 2/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP19A1 P11511 1/20 0.32
GLA P06280 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143235 0.88 MAPK14 (0.39) MAPK14HCRTR1HCRTR2
SCHEMBL7145378 0.85 ADRA2A (0.35) ADRA2ADRD5DRD3P2RY6NPC1
SCHEMBL7146023 0.81 MAPK14 (0.39) MAPK14CASP3SENP8SENP7SENP6
SCHEMBL7147209 0.81 RORC (0.36) MAPK14SIRT2
SCHEMBL7146760 0.80 ALDH1A1 (0.39) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL7138020 0.80 ALDH1A1 (0.39) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL7143195 0.80 FFAR1 (0.39) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL7138026 0.79 MAPT (0.41) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL7139782 0.79 MEN1 (0.36) ADRA2ADRD5DRD3P2RY6NPC1
SCHEMBL7143531 0.78 ALDH1A1 (0.41) NPC1RAB9AMAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed